Xeris Biopharma: Potential to Get Development Payments, Plus Low Double-Digit Royalties Based on Future Sales of Xeris Glucagon for Pumps, Pump Systems
Xeris Biopharma:根據用於泵、泵系統的Xeris胰高血糖素的未來銷售情況,有可能獲得開發報酬,外加低的兩位數特許權使用費
Xeris Biopharma: Potential to Get Development Payments, Plus Low Double-Digit Royalties Based on Future Sales of Xeris Glucagon for Pumps, Pump Systems
Xeris Biopharma:根據用於泵、泵系統的Xeris胰高血糖素的未來銷售情況,有可能獲得開發報酬,外加低的兩位數特許權使用費
使用瀏覽器的分享功能,分享給你的好友吧